Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Lloyds Banking Group Plc American Depositary Shares (LYG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Lloyds Banking Group Plc American Depositary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.28 (market cap $12.58B), while Lloyds Banking Group Plc American Depositary Shares trades at $5.4 (market cap $76.34B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 6.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 4.05% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Lloyds Banking Group Plc American Depositary Shares for 1 Days on average.
| HALO | LYG | |
|---|---|---|
Market Cap | $12.58B | $76.34B |
Volume | 2,179,278 | 16,671,733 |
Sector | Health | Financials |
52-Week High | $115.22 | $6.28 |
52-Week Low | $61.63 | $4.42 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $99.66B |
Dividend Yield | — | 4.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Lloyds Banking Group Plc American Depositary Shares
Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.
Read more on LYG →
